Clinical Trials · NCT01535027
Combined Administration of Teripapartide and Antiresorptive Agents in Postmenopausal Osteoporosis
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Medical University of Vienna
- Enrollment
- 125
- Start date
- Mar 2006
- Locations
- 1 site, Austria
- Primary endpoint
- Differences in changes of areal lumbar spine BMD between the three treatment groups